124 related articles for article (PubMed ID: 38835114)
1. Distinctive contribution of two additional residues in protein aggregation of Aβ42 and Aβ40 isoforms.
Im D; Choi TS
BMB Rep; 2024 Jun; 57(6):263-272. PubMed ID: 38835114
[TBL] [Abstract][Full Text] [Related]
2. N-Terminus Binding Preference for Either Tanshinone or Analogue in Both Inhibition of Amyloid Aggregation and Disaggregation of Preformed Amyloid Fibrils-Toward Introducing a Kind of Novel Anti-Alzheimer Compounds.
Dong M; Zhao W; Hu D; Ai H; Kang B
ACS Chem Neurosci; 2017 Jul; 8(7):1577-1588. PubMed ID: 28406293
[TBL] [Abstract][Full Text] [Related]
3. Aβ42 and Aβ40: similarities and differences.
Qiu T; Liu Q; Chen YX; Zhao YF; Li YM
J Pept Sci; 2015 Jul; 21(7):522-9. PubMed ID: 26018760
[TBL] [Abstract][Full Text] [Related]
4. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
[TBL] [Abstract][Full Text] [Related]
5. The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway.
Chang YJ; Chen YR
FEBS J; 2014 Jun; 281(11):2674-87. PubMed ID: 24720730
[TBL] [Abstract][Full Text] [Related]
6. A new structural model of Alzheimer's Aβ42 fibrils based on electron paramagnetic resonance data and Rosetta modeling.
Gu L; Tran J; Jiang L; Guo Z
J Struct Biol; 2016 Apr; 194(1):61-7. PubMed ID: 26827680
[TBL] [Abstract][Full Text] [Related]
7. Dissecting the Molecular Mechanisms of the Co-Aggregation of Aβ40 and Aβ42 Peptides: A REMD Simulation Study.
Li X; Yang Z; Chen Y; Zhang S; Wei G; Zhang L
J Phys Chem B; 2023 May; 127(18):4050-4060. PubMed ID: 37126408
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's Aβ42 and Aβ40 peptides form interlaced amyloid fibrils.
Gu L; Guo Z
J Neurochem; 2013 Aug; 126(3):305-11. PubMed ID: 23406382
[TBL] [Abstract][Full Text] [Related]
9. Different Aggregation Pathways and Structures for Aβ40 and Aβ42 Peptides.
Wang L; Eom K; Kwon T
Biomolecules; 2021 Jan; 11(2):. PubMed ID: 33573350
[TBL] [Abstract][Full Text] [Related]
10. Analysis of Non-Amyloidogenic Mutations in APP Supports Loss of Function Hypothesis of Alzheimer's Disease.
Kim M; Bezprozvanny I
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768421
[TBL] [Abstract][Full Text] [Related]
11. Molecular Insights into the Inhibition and Disaggregation Effects of EGCG on Aβ40 and Aβ42 Cofibrillation.
Li X; Zhang Y; Wang Y; Zhang S; Zhang L
J Phys Chem B; 2024 Feb; 128(8):1843-1853. PubMed ID: 38359305
[TBL] [Abstract][Full Text] [Related]
12. Familial Alzheimer's disease mutations at position 22 of the amyloid β-peptide sequence differentially affect synaptic loss, tau phosphorylation and neuronal cell death in an ex vivo system.
Tackenberg C; Kulic L; Nitsch RM
PLoS One; 2020; 15(9):e0239584. PubMed ID: 32966331
[TBL] [Abstract][Full Text] [Related]
13. The ratio of monomeric to aggregated forms of Abeta40 and Abeta42 is an important determinant of amyloid-beta aggregation, fibrillogenesis, and toxicity.
Jan A; Gokce O; Luthi-Carter R; Lashuel HA
J Biol Chem; 2008 Oct; 283(42):28176-89. PubMed ID: 18694930
[TBL] [Abstract][Full Text] [Related]
14. Key Residue for Aggregation of Amyloid-β Peptides.
Itoh SG; Yagi-Utsumi M; Kato K; Okumura H
ACS Chem Neurosci; 2022 Nov; 13(22):3139-3151. PubMed ID: 36302506
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide analysis of Saccharomyces cerevisiae identifies cellular processes affecting intracellular aggregation of Alzheimer's amyloid-β42: importance of lipid homeostasis.
Nair S; Traini M; Dawes IW; Perrone GG
Mol Biol Cell; 2014 Aug; 25(15):2235-49. PubMed ID: 24870034
[TBL] [Abstract][Full Text] [Related]
16. Influence of the familial Alzheimer's disease-associated T43I mutation on the transmembrane structure and γ-secretase processing of the C99 peptide.
Tang TC; Kienlen-Campard P; Hu Y; Perrin F; Opsomer R; Octave JN; Constantinescu SN; Smith SO
J Biol Chem; 2019 Apr; 294(15):5854-5866. PubMed ID: 30755484
[TBL] [Abstract][Full Text] [Related]
17. Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.
Ferrera D; Mazzaro N; Canale C; Gasparini L
Neurobiol Aging; 2014 Nov; 35(11):2444-2457. PubMed ID: 24973120
[TBL] [Abstract][Full Text] [Related]
18. Short Aβ peptides attenuate Aβ42 toxicity in vivo.
Moore BD; Martin J; de Mena L; Sanchez J; Cruz PE; Ceballos-Diaz C; Ladd TB; Ran Y; Levites Y; Kukar TL; Kurian JJ; McKenna R; Koo EH; Borchelt DR; Janus C; Rincon-Limas D; Fernandez-Funez P; Golde TE
J Exp Med; 2018 Jan; 215(1):283-301. PubMed ID: 29208777
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease amyloid β-protein mutations and deletions that define neuronal binding/internalization as early stage nonfibrillar/fibrillar aggregates and late stage fibrils.
Poduslo JF; Howell KG; Olson NC; Ramirez-Alvarado M; Kandimalla KK
Biochemistry; 2012 May; 51(19):3993-4003. PubMed ID: 22545812
[TBL] [Abstract][Full Text] [Related]
20. Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes.
Qiang W; Yau WM; Lu JX; Collinge J; Tycko R
Nature; 2017 Jan; 541(7636):217-221. PubMed ID: 28052060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
